0000905148-24-001568.txt : 20240521
0000905148-24-001568.hdr.sgml : 20240521
20240521161802
ACCESSION NUMBER: 0000905148-24-001568
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240517
FILED AS OF DATE: 20240521
DATE AS OF CHANGE: 20240521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Magrath George
CENTRAL INDEX KEY: 0001999390
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34079
FILM NUMBER: 24969593
MAIL ADDRESS:
STREET 1: 37000 GRAND RIVER AVE
STREET 2: SUITE 120
CITY: FARMINGTON HILLS
STATE: MI
ZIP: 48335
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ocuphire Pharma, Inc.
CENTRAL INDEX KEY: 0001228627
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 113516358
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 37000 GRAND RIVER AVE.
STREET 2: SUITE 120
CITY: FARMINGTON HILLS
STATE: MI
ZIP: 48335
BUSINESS PHONE: 248-681-9815
MAIL ADDRESS:
STREET 1: 37000 GRAND RIVER AVE.
STREET 2: SUITE 120
CITY: FARMINGTON HILLS
STATE: MI
ZIP: 48335
FORMER COMPANY:
FORMER CONFORMED NAME: REXAHN PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20050516
FORMER COMPANY:
FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC
DATE OF NAME CHANGE: 20030423
4
1
form4.xml
X0508
4
2024-05-17
0001228627
Ocuphire Pharma, Inc.
OCUP
0001999390
Magrath George
C/O OCUPHIRE PHARMA, INC.
37000 GRAND RIVER AVE, SUITE 120
FARMINGTON HILLS
MI
48335
true
Chief Executive Officer
false
Common Stock
2024-05-17
4
P
0
5000
1.7545
A
430000
D
The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.73 to $1.78, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Amy Rabourn, by Power of Attorney
2024-05-21